Ledger.Open graph →

SEC Form D · filed December 24, 2013

Variation Biotechnologies (US), Inc

Offering

$1.4M

Sold

$1.4M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jeff Baxter · Cambridge, MAExec · Director Egidio Nascimento · Cambridge, MAExec David E. Anderson · Cambridge, MAExec Kevin Forrest · Cambridge, MADirector Michael Steinmetz · Cambridge, MADirector Stephen Gillis · Cambridge, MADirector Marc J. Kirchmeier · Cambridge, MAExec Adam Buckley · Cambridge, MAExec Steve Vignau · CAMBRIDGE, MADirector Richard Harwood · St Helier, Y9Exec · Director Philip B. Mullin · BATTLE GROUND, WAExec Gary Redding · BOHEMIA, NYDirector Michael Eisenberg · Tel Aviv, L3Director Eden Shochat · Tel Aviv, L3Director Tim Mcpike · Calgary, Alberta, CanadaExec Peter W. Bardaglio · Trumansburg, NYExec Matthew W. Clark · Ithaca, NYExec Steve Vignau · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗